AHA Schedule 2014: Difference between revisions
Jump to navigation
Jump to search
| (29 intermediate revisions by the same user not shown) | |||
| Line 60: | Line 60: | ||
===2:00 PM=== | ===2:00 PM=== | ||
''2:00 PM - 2:30 PM'' | |||
*'''Interviewee:''' Dr. Joseph Muhlestein | |||
*'''Topic:''' Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using Coronary CT Angiography: Primary Results of FACTOR-64, a Randomized Controlled Trial | |||
*'''Embargo Lift:''' Monday, November 17, 2014 at 11:07 AM | |||
===2:30 PM=== | ===2:30 PM=== | ||
| Line 83: | Line 86: | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===8: | ===8:45 AM=== | ||
''8:45 AM - 9:00 AM'' | |||
*'''Interviewee:''' Dr. Stefanie Schulz | |||
*'''Topic:''' Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE) | |||
*'''Embargo Lift:''' Sunday, November 16, 2014 at 3:55 PM | |||
===9:00 AM=== | ===9:00 AM=== | ||
''9:00 AM - 9:30 AM'' | |||
*'''Interviewee:''' Dr. Kirk N. Garratt | |||
*'''Topic:''' Increased Risk of Ischemic Events Upon Discontinuation of Prasugrel After 12 or 30 Months of Therapy Following Placement of the Taxus Liberté Paclitaxel- Eluting Coronary Stent | |||
*'''Embargo Lift:''' Sunday, November 16, 2014 at 4:05 PM | |||
===9:30 AM=== | ===9:30 AM=== | ||
''9:30 AM - 10:00 AM'' | |||
*'''Interviewee:''' Dr. Martine Gilard | |||
*'''Topic:''' Is 6 Months DAPT Post Coronary Stenting Non Inferior To 24 Months? The Italic/ Italic+ Randomized Trial. Results of the One Year Primary Endpoint | |||
*'''Embargo Lift:''' Sunday, November 16, 2014 at 4:05 PM | |||
===10:00 AM=== | ===10:00 AM=== | ||
| Line 99: | Line 111: | ||
===11:00 AM=== | ===11:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
| Line 133: | Line 127: | ||
===4:30 PM=== | ===4:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
==Monday, November 17, 2014== | ==Monday, November 17, 2014== | ||
===8:00 AM=== | ===8:00 AM=== | ||
''8:00 AM - 8:30 AM'' | |||
*'''Interviewee:''' Dr. Christopher Granger and Dr. James Jollis | |||
*'''Topic:''' Developing Regional STEMI Systems of Care: Final Results of the Mission: Lifeline STEMI ACCELERATOR Study | |||
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 11:41 AM | |||
===8:30 AM=== | ===8:30 AM=== | ||
''8:30 AM - 9:00 AM'' | |||
*'''Interviewee:''' Dr. Christoph Kaiser | |||
*'''Topic:''' Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-eluting Stents and Bare Metal Stents - Main Results of a Prospective Randomized Trial | |||
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 10:45 AM | |||
===9:00 AM=== | ===9:00 AM=== | ||
''9:00 AM - 9:15 AM'' | |||
*'''Interviewee:''' Dr. Patrick Moriarty | |||
*'''Topic:''' ODYSSEY ALTERNATIVE: Efficacy And Safety of the Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibody, Alirocumab, versus Ezetimibe, in Patients With Statin Intolerance as Defined by a Placebo Run-in and Statin Rechallenge Arm | |||
*'''Embargo Lift:''' Monday, November 17, 2014 at 11:29 AM | |||
===9:15 AM=== | |||
''9:15 AM - 9:30 AM'' | |||
*'''Interviewee:''' Dr. Robert Giugliano | |||
*'''Topic:''' IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes | |||
*'''Embargo Lift:''' Monday, November 17, 2014 at 11:51 AM | |||
===9:30 AM=== | ===9:30 AM=== | ||
''9:30 AM - 10:00 AM'' | |||
*'''Interviewee:''' Dr. Renato Lopes | |||
*'''Topic:''' AHA 2014 Wrap-Up in Portuguese | |||
===10:00 AM=== | ===10:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font | <font color=red>OPEN TIME SLOT</font | ||
===10:30 AM=== | ===10:30 AM=== | ||
| Line 171: | Line 181: | ||
===1:30 PM=== | ===1:30 PM=== | ||
''1:30 PM - 2:00 PM'' | |||
*'''Interviewee:''' Dr. Philip Aylward | |||
*'''Topic:''' AHA 2014 Wrap-Up from a Pacific Rim perspective | |||
===2:00 PM=== | ===2:00 PM=== | ||
| Line 177: | Line 189: | ||
===2:30 PM=== | ===2:30 PM=== | ||
''2:30 PM - 3:00 PM'' | |||
*'''Interviewee:''' Dr. Paul Armstrong, Dr. Justin Ezekowitz, Dr. Robert Welsh and Dr. Shaun Goodman | |||
*'''Topic:''' AHA 2014 Wrap-Up from a Canadian perspective | |||
===3:00 PM=== | ===3:00 PM=== | ||
| Line 183: | Line 197: | ||
===3:30 PM=== | ===3:30 PM=== | ||
''3:30 PM - 4:00 PM'' | |||
*'''Interviewee:''' Dr. Samuel Wright | |||
*'''Topic:''' CSL112 Posters: “CSL112 Enhances Cholesterol Efflux Equally in Patients with high and Low HDL Functionality” and “Mechanism of HDL remodeling induced by CSL112”) | |||
*'''Embargo Lift:''' Tuesday, November 18, 2014 | |||
===4:00 PM=== | ===4:00 PM=== | ||
''4:00 PM - 4:15 PM'' | |||
*'''Interviewee:''' Dr. Basil Lewis | |||
*'''Topic:''' AHA 2014 Wrap-Up in Hebrew | |||
===4:15 PM=== | |||
''4:15 PM - 4:45 PM'' | |||
*'''Interviewee:''' Dr. Kazuyuki Shimada | |||
*'''Topic:''' Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Patients With Multiple Atherosclerotic Risk Factors: A Randomized Controlled Trial | |||
*'''Embargo Lift:''' Monday, November 17, 2014 at 10:45 AM | |||
=== | ===5:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===5:30 PM=== | |||
''5:30 PM - 6:00 PM'' | |||
*'''Interviewee:''' Dr. Gilles Montalescot | |||
*'''Topic:''' AHA 2014 Wrap-Up in French | |||
==Tuesday, November 18, 2014== | ==Tuesday, November 18, 2014== | ||
===7:30 AM=== | |||
''7:30 AM - 8:00 AM'' | |||
*'''Interviewee:''' Dr. Robert Michler | |||
*'''Topic:''' The Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial From The Cardiothoracic Surgical Trials Network | |||
*'''Embargo Lift:''' Tuesday, November 18, 2014 at 11:51 AM | |||
===8:00 AM=== | ===8:00 AM=== | ||
| Line 201: | Line 236: | ||
===9:00 AM=== | ===9:00 AM=== | ||
''9:00 AM - 9:30 AM'' | |||
*'''Interviewee:''' Dr. Dean Kereiakes | |||
*'''Topic:''' Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent | |||
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 10:55 AM | |||
===9:30 AM=== | ===9:30 AM=== | ||
| Line 236: | Line 274: | ||
===2:00 PM=== | ===2:00 PM=== | ||
''2:00 PM - 2:30 PM'' | |||
*'''Interviewee:''' Dr. Stefan James | |||
*'''Topic:''' AHA 2014 Wrap-Up from a Scandinavian perspective | |||
===2:30 PM=== | ===2:30 PM=== | ||
''2:30 PM - 3:00 PM'' | |||
*'''Interviewee:''' Dr. Mark Dayer | |||
*'''Topic:''' The Incidence of Infective Endocarditis in England is Increasing - An Assessment of the Impact of Cessation of Antibiotic Prophylaxis Using Population Statistics | |||
*'''Embargo Lift:''' Tuesday, November 18, 2014 at 11:29 AM | |||
===3:00 PM=== | ===3:00 PM=== | ||
''3:00 PM - 3:30 PM'' | |||
*'''Interviewee:''' Dr. Freek W.A. Verheugt | |||
*'''Topic:''' AHA 2014 Wrap-Up from a Netherlands perspective | |||
===3:30 PM=== | ===3:30 PM=== | ||
| Line 268: | Line 313: | ||
===10:00 AM=== | ===10:00 AM=== | ||
''10:00 AM - 10:30 AM'' | |||
*'''Interviewee:''' Dr. Anna Axelsson | |||
*'''Topic:''' A Randomized Trial of Losartan In Hypertrophic Cardiomyopathy - The INHERIT Trial | |||
*'''Embargo Lift:''' Tuesday, November 18, 2014 at 11:07 AM | |||
===10:30 AM=== | ===10:30 AM=== | ||
''10:30 AM - 11:00 AM'' | |||
*'''Interviewee:''' Dr. Laura Mauri | |||
*'''Topic:''' Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study | |||
*'''Embargo Lift:''' Sunday, November 16, 2014 at 4:15 PM | |||
===11:00 AM=== | ===11:00 AM=== | ||
''11:00 AM - 11:30 AM'' | |||
*'''Interviewee:''' Dr. Westby Fisher | |||
*'''Topic:''' ABIM Maintenance of Certification program | |||
===11:30 AM=== | ===11:30 AM=== | ||
| Line 301: | Line 354: | ||
===3:30 PM=== | ===3:30 PM=== | ||
''3:30 PM - 4:00 PM'' | |||
*'''Interviewee:''' Prof. Dr. Sigmund Silber | |||
*'''Topic:''' AHA 2014 Wrap-Up in German | |||
===4:00 PM=== | ===4:00 PM=== | ||
Latest revision as of 16:49, 13 November 2014
Here is the page we will use to coordinate the TV events at AHA 2014. Open time slots are indicated below in red.
Filming Location: Hyatt Regency McCormick Place, 2233 S. Martin Luther King Drive, Chicago, IL 60616
Click on Date for Detailed Schedule
Saturday, November 15, 2014
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Joseph Muhlestein
- Topic: Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using Coronary CT Angiography: Primary Results of FACTOR-64, a Randomized Controlled Trial
- Embargo Lift: Monday, November 17, 2014 at 11:07 AM
2:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
Sunday, November 16, 2014
8:00 AM
OPEN TIME SLOT
8:45 AM
8:45 AM - 9:00 AM
- Interviewee: Dr. Stefanie Schulz
- Topic: Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE)
- Embargo Lift: Sunday, November 16, 2014 at 3:55 PM
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. Kirk N. Garratt
- Topic: Increased Risk of Ischemic Events Upon Discontinuation of Prasugrel After 12 or 30 Months of Therapy Following Placement of the Taxus Liberté Paclitaxel- Eluting Coronary Stent
- Embargo Lift: Sunday, November 16, 2014 at 4:05 PM
9:30 AM
9:30 AM - 10:00 AM
- Interviewee: Dr. Martine Gilard
- Topic: Is 6 Months DAPT Post Coronary Stenting Non Inferior To 24 Months? The Italic/ Italic+ Randomized Trial. Results of the One Year Primary Endpoint
- Embargo Lift: Sunday, November 16, 2014 at 4:05 PM
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
2:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
Monday, November 17, 2014
8:00 AM
8:00 AM - 8:30 AM
- Interviewee: Dr. Christopher Granger and Dr. James Jollis
- Topic: Developing Regional STEMI Systems of Care: Final Results of the Mission: Lifeline STEMI ACCELERATOR Study
- Embargo Lift: Wednesday, November 19, 2014 at 11:41 AM
8:30 AM
8:30 AM - 9:00 AM
- Interviewee: Dr. Christoph Kaiser
- Topic: Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-eluting Stents and Bare Metal Stents - Main Results of a Prospective Randomized Trial
- Embargo Lift: Wednesday, November 19, 2014 at 10:45 AM
9:00 AM
9:00 AM - 9:15 AM
- Interviewee: Dr. Patrick Moriarty
- Topic: ODYSSEY ALTERNATIVE: Efficacy And Safety of the Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibody, Alirocumab, versus Ezetimibe, in Patients With Statin Intolerance as Defined by a Placebo Run-in and Statin Rechallenge Arm
- Embargo Lift: Monday, November 17, 2014 at 11:29 AM
9:15 AM
9:15 AM - 9:30 AM
- Interviewee: Dr. Robert Giugliano
- Topic: IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes
- Embargo Lift: Monday, November 17, 2014 at 11:51 AM
9:30 AM
9:30 AM - 10:00 AM
- Interviewee: Dr. Renato Lopes
- Topic: AHA 2014 Wrap-Up in Portuguese
10:00 AM
OPEN TIME SLOT</font
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
1:30 PM - 2:00 PM
- Interviewee: Dr. Philip Aylward
- Topic: AHA 2014 Wrap-Up from a Pacific Rim perspective
2:00 PM
OPEN TIME SLOT
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. Paul Armstrong, Dr. Justin Ezekowitz, Dr. Robert Welsh and Dr. Shaun Goodman
- Topic: AHA 2014 Wrap-Up from a Canadian perspective
3:00 PM
OPEN TIME SLOT
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Samuel Wright
- Topic: CSL112 Posters: “CSL112 Enhances Cholesterol Efflux Equally in Patients with high and Low HDL Functionality” and “Mechanism of HDL remodeling induced by CSL112”)
- Embargo Lift: Tuesday, November 18, 2014
4:00 PM
4:00 PM - 4:15 PM
- Interviewee: Dr. Basil Lewis
- Topic: AHA 2014 Wrap-Up in Hebrew
4:15 PM
4:15 PM - 4:45 PM
- Interviewee: Dr. Kazuyuki Shimada
- Topic: Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Patients With Multiple Atherosclerotic Risk Factors: A Randomized Controlled Trial
- Embargo Lift: Monday, November 17, 2014 at 10:45 AM
5:00 PM
OPEN TIME SLOT
5:30 PM
5:30 PM - 6:00 PM
- Interviewee: Dr. Gilles Montalescot
- Topic: AHA 2014 Wrap-Up in French
Tuesday, November 18, 2014
7:30 AM
7:30 AM - 8:00 AM
- Interviewee: Dr. Robert Michler
- Topic: The Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial From The Cardiothoracic Surgical Trials Network
- Embargo Lift: Tuesday, November 18, 2014 at 11:51 AM
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. Dean Kereiakes
- Topic: Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
- Embargo Lift: Wednesday, November 19, 2014 at 10:55 AM
9:30 AM
OPEN TIME SLOT
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Dr. Dion Stub
- Topic: A Randomised Controlled Trial of Oxygen Therapy in Acute St-segment Elevation Myocardial Infarction: The Air Versus Oxygen in Myocardial Infarction (AVOID) Study
- Embargo Lift: Wednesday, November 19, 2014 at 11:19 AM
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
12:00 PM
12:00 PM - 12:30 PM
- Interviewee: Dr. Hisao Ogawa
- Topic: AHA 2014 Wrap-Up in Japanese
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Stefan James
- Topic: AHA 2014 Wrap-Up from a Scandinavian perspective
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. Mark Dayer
- Topic: The Incidence of Infective Endocarditis in England is Increasing - An Assessment of the Impact of Cessation of Antibiotic Prophylaxis Using Population Statistics
- Embargo Lift: Tuesday, November 18, 2014 at 11:29 AM
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: Dr. Freek W.A. Verheugt
- Topic: AHA 2014 Wrap-Up from a Netherlands perspective
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
Wednesday, November 19, 2014
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Dr. Anna Axelsson
- Topic: A Randomized Trial of Losartan In Hypertrophic Cardiomyopathy - The INHERIT Trial
- Embargo Lift: Tuesday, November 18, 2014 at 11:07 AM
10:30 AM
10:30 AM - 11:00 AM
- Interviewee: Dr. Laura Mauri
- Topic: Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study
- Embargo Lift: Sunday, November 16, 2014 at 4:15 PM
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Westby Fisher
- Topic: ABIM Maintenance of Certification program
11:30 AM
OPEN TIME SLOT
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Prof. Dr. Sigmund Silber
- Topic: AHA 2014 Wrap-Up in German
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT